Blogs
Healthcare and Medtech Research Reports
Notizia - Recent Pharma, Healthcare and Biotech Happenings
Sarepta builds in gene therapy with $30M Lacerta deal Sarepta has dampen its enthusiasm for an ongoing gene therapy candidate. Sarepta has made a tie-up with lacerta that will add 3 more programs to 8 already existing and are ready to expand its focus beyond muscular dystrophy. Sarepta has committed to pay Lacerta development and sales-based milestones adding single-digit royalties on net sales under the terms of the deal. The tie-up with Lacerta follows an alliance with Myonexus for five gene therapy programs focusing on limb girdle muscular dystrophy (LGMD).Sarepta’s lead DMD gene therapy was placed under hold because of a quality issue .shares in the company raised...
Explore More...